<DOC>
	<DOC>NCT00979927</DOC>
	<brief_summary>The purpose of this study is to investigate the safety and tolerability of SPC3649 given in multiple doses to healthy volunteers.</brief_summary>
	<brief_title>SPC3649 Multiple Dose Study in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy volunteers: Males and postmenopausal females aged â‰¥ 18 to 60 years</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2011</verification_date>
	<keyword>Antisense</keyword>
	<keyword>miR-122 antagonist</keyword>
	<keyword>safety in healthy Volunteers</keyword>
	<keyword>Hepatitis C</keyword>
</DOC>